Pages that link to "Q36967857"
Jump to navigation
Jump to search
The following pages link to Recent progress in antiretrovirals--lessons from resistance (Q36967857):
Displaying 21 items.
- EASY-HIT: HIV Full-Replication Technology for Broad Discovery of Multiple Classes of HIV Inhibitors (Q24606095) (← links)
- HIV type 1 Gag as a target for antiviral therapy (Q24614498) (← links)
- Virus maturation as a new HIV-1 therapeutic target (Q24642446) (← links)
- Novel approaches to inhibiting HIV-1 replication. (Q33624690) (← links)
- Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets (Q33819240) (← links)
- HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice (Q34529834) (← links)
- Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication (Q34668776) (← links)
- New findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1 (Q35091548) (← links)
- Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis. (Q35120811) (← links)
- New Insights into HIV Assembly and Trafficking (Q36307738) (← links)
- Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457) (Q37192174) (← links)
- Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription (Q37273867) (← links)
- Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland (Q37643256) (← links)
- Does Antiretroviral Therapy Improve HIV-Associated Cognitive Impairment? A Quantitative Review of the Literature (Q37911001) (← links)
- HIV-1 gag: an emerging target for antiretroviral therapy. (Q38366763) (← links)
- 3-Phenylcoumarins as inhibitors of HIV-1 replication. (Q39303248) (← links)
- An optimized MM/PBSA virtual screening approach applied to an HIV-1 gp41 fusion peptide inhibitor. (Q39698701) (← links)
- Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways (Q40325450) (← links)
- Quantitative prediction of integrase inhibitor resistance from genotype through consensus linear regression modeling (Q42919375) (← links)
- Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites (Q46213246) (← links)
- Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites (Q51002244) (← links)